A new leader for Pfizer Australia following a promotion for David Gallagher.
Mr Gallagher will return to his native Ireland to lead a large group of countries across Eastern Europe from 1 July. He will be succeeded by Melissa McGregor.
Mr Gallagher departs Australia after three years leading the local company, including a stint on the Board of Medicines Australia. He came to Australia after 13 years with Pfizer, having led its business in Ireland and served as President of that country’s equivalent to Medicines Australia, the Irish Pharmaceutical Healthcare Association.
“David has brought an immense amount of professionalism and dedication to serving patients and is held in high regard by many, including his colleagues in Australia and New Zealand,” said Mr Richard Blackburn, Regional President International Developed Markets.
“I take this opportunity to thank David for his outstanding contribution to the Australian and New Zealand business over the past three years and look forward to seeing Melissa build upon the strong legacy that he leaves behind.”
Ms McGregor is a returning Australian and will be based in Sydney. She has served as Country Manager, Pfizer New Zealand, for the past two years.
The company said Ms McGregor had presided over strong growth in New Zealand.
"Contributing to that success are innovative market access approaches for our medicines, active involvement with the NZ industry association (Medicines New Zealand) and initiatives to profile Pfizer’s wider contribution to New Zealand," said the company.
Ms McGregor has been with Pfizer for 18 years and has performed roles in sales, marketing, commercial and training.
“I am delighted to be appointed to the role,” said Ms McGregor. “I look forward to working with our key partners to ensure we continue delivering for the patients who are counting on us.”
“Melissa will continue our commitment to work closely with all relevant stakeholders, to help enable people across Australia to have access to the medicines they need,” said Mr Blackburn.
